...
首页> 外文期刊>European journal of human genetics: EJHG >Identification of potential microRNA-target pairs associated with osteopetrosis by deep sequencing, iTRAQ proteomics and bioinformatics
【24h】

Identification of potential microRNA-target pairs associated with osteopetrosis by deep sequencing, iTRAQ proteomics and bioinformatics

机译:通过深度测序,iTRAQ蛋白质组学和生物信息学鉴定与骨质疏松症相关的潜在microRNA-靶标对

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs aberrantly express in many human diseases including some metabolic bone disorders. They have been found to be associated with osteoclast differentiation and function, which makes them attractive candidates for the therapy of bone. However, the potential clinical application of microRNAs in therapeutics rests heavily upon our in-depth understanding of microRNAs and their targets. To identify potential microRNA-target pairs associated with osteopetrosis, we performed a system approach including deep sequencing, iTRAQ quantitative proteomics, and bioinformatics in the peripheral blood mononuclear cells (PBMCs) taken from patients with osteopetrosis and health donors. Notably, 123 differently expressed microRNAs, 173 differently expressed proteins, and 117 computationally predicted microRNA-target pairs with reciprocally expressed level in PBMCs were found in the two sample groups. Functional annotation identified that the microRNA-target pairs were involved in cell growth, differentiation, cellular signaling network, and the network highlighted the microRNA-target pair of has-miR-320a and ADP ribosylation factor 1 (Arf1) potentially associated with CLCN7 mutations in osteopetrosis. The pair of has-miR-320a and Arf1 was further verified by real-time PCR, western blot, and the interaction between has-miR-320a and its targeted sequence on the Arf1 mRNAs was confirmed by luciferase assay. Collectively, the present study established a new system approach for the investigation of microRNAs, and the microRNA-target pairs, particular has-miR-320a and Arf1, may have important roles in osteopetrosis.
机译:MicroRNA在许多人类疾病中异常表达,包括某些代谢性骨疾病。已经发现它们与破骨细胞的分化和功能有关,这使其成为骨疗法的有吸引力的候选者。但是,microRNA在治疗中的潜在临床应用在很大程度上取决于我们对microRNA及其靶标的深入了解。为了鉴定与骨质疏松症相关的潜在microRNA-靶标对,我们在从骨质疏松症患者和健康捐助者那里获取的外周血单核细胞(PBMC)中进行了包括深度测序,iTRAQ定量蛋白质组学和生物信息学在内的系统方法。值得注意的是,在两个样本组中发现了123个不同表达的microRNA,173个不同表达的蛋白质和117个在PBMC中具有相互表达水平的预测的microRNA-靶标对。功能注释确定microRNA-靶标对参与细胞生长,分化,细胞信号网络,并且该网络突出显示了可能与CLCN7突变相关的has-miR-320a和ADP核糖基化因子1(Arf1)的microRNA-靶标对。骨质疏松症。 has-miR-320a和Arf1对通过实时PCR,western blot进一步验证,并且has-miR-320a及其靶序列在Arf1 mRNA上的相互作用已通过荧光素酶测定得以证实。总体而言,本研究建立了一种新的系统方法来研究microRNA,并且microRNA-靶标对,特别是has-miR-320a和Arf1,可能在骨科学中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号